Beyond Discovery: Making Immunotherapies Scalable, Accessible, and Transformative

Gene editing has transformed cancer immunotherapy, enabling precise modifications to immune cells to enhance their ability to target and eliminate disease. Advanced gene editing tools—including CRISPR-Cas nucleases, base editors, prime editors, sgRNA, HDR templates, and high-fidelity enzymes—have facilitated the development of CAR-T, TCR-engineered, and NK cells with improved specificity, persistence, and potency. These technologies are driving innovation in cell therapy, offering new avenues for effective treatments.

As gene editing innovations continue to reshape cell therapy, the need for scalable, efficient, and regulatory-compliant manufacturing solutions has never been greater. This webinar will showcase how GenScript’s automation and advanced gene editing technologies streamline the journey from discovery to manufacturing, accelerating the development of life-saving therapies.

Learning Objectives:

1. Explore advanced gene editing tools driving next-generation cell therapies.

2. Explore scalable and regulatory-compliant manufacturing solutions for gene-edited cell therapies.

3. Integrated Solutions from Discovery to Clinical Manufacturing.